Literature DB >> 23989160

Fibronectin type III domains engineered to bind CD40L: cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of two complexes.

Vaheh Oganesyan1, Andrew Ferguson, Luba Grinberg, Lin Wang, Sandrina Phipps, Benoy Chacko, Stacey Drabic, Thomas Thisted, Manuel Baca.   

Abstract

Tn3 proteins are a novel class of binding molecules based on the third fibronectin type III domain of human tenascin C. Target-specific Tn3 proteins are selected from combinatorial libraries in which three surface-exposed loops have been diversified. Here, the cocrystallization of two different Tn3 proteins in complex with CD40L, a therapeutic target for immunological disease, is reported. These crystal structures are the first to be reported of Tn3 proteins and will help to reveal how these engineered molecules achieve specific recognition of a cognate target.

Entities:  

Keywords:  CD40L; fibronectin type III domains

Mesh:

Substances:

Year:  2013        PMID: 23989160      PMCID: PMC3758160          DOI: 10.1107/S1744309113022847

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  13 in total

1.  Target-binding proteins based on the 10th human fibronectin type III domain (¹⁰Fn3).

Authors:  Shohei Koide; Akiko Koide; Daša Lipovšek
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  Likelihood-enhanced fast translation functions.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Laurent C Storoni; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-03-24

Review 3.  Alternative non-antibody scaffolds for molecular recognition.

Authors:  Arne Skerra
Journal:  Curr Opin Biotechnol       Date:  2007-07-20       Impact factor: 9.740

4.  The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators.

Authors:  Nazzareno Dimasi; Changshou Gao; Ryan Fleming; Robert M Woods; Xiao-Tao Yao; Lena Shirinian; Peter A Kiener; Herren Wu
Journal:  J Mol Biol       Date:  2009-08-20       Impact factor: 5.469

Review 5.  Non-immunoglobulin based protein scaffolds.

Authors:  John Löfblom; Fredrik Y Frejd; Stefan Ståhl
Journal:  Curr Opin Biotechnol       Date:  2011-07-02       Impact factor: 9.740

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

7.  2 A crystal structure of an extracellular fragment of human CD40 ligand.

Authors:  M Karpusas; Y M Hsu; J H Wang; J Thompson; S Lederman; L Chess; D Thomas
Journal:  Structure       Date:  1995-10-15       Impact factor: 5.006

8.  Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein.

Authors:  D J Leahy; W A Hendrickson; I Aukhil; H P Erickson
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

9.  Multivalent scaffold proteins as superagonists of TRAIL receptor 2-induced apoptosis.

Authors:  Jeffery S Swers; Luba Grinberg; Lin Wang; Hui Feng; Kristen Lekstrom; Rosa Carrasco; Zhan Xiao; Ivan Inigo; Ching Ching Leow; Herren Wu; David A Tice; Manuel Baca
Journal:  Mol Cancer Ther       Date:  2013-05-03       Impact factor: 6.261

10.  High-resolution design of a protein loop.

Authors:  Xiaozhen Hu; Huanchen Wang; Hengming Ke; Brian Kuhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

View more
  3 in total

1.  The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys.

Authors:  Simone M Nicholson; Kerry A Casey; Michele Gunsior; Stacey Drabic; William Iverson; Halie Cook; Stephen Scott; Terry O'Day; Subramanya Karanth; Rakesh Dixit; Patricia C Ryan
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

Review 2.  Monobodies as enabling tools for structural and mechanistic biology.

Authors:  Oliver Hantschel; Matthew Biancalana; Shohei Koide
Journal:  Curr Opin Struct Biol       Date:  2020-03-04       Impact factor: 6.809

Review 3.  Development and Differentiation in Monobodies Based on the Fibronectin Type 3 Domain.

Authors:  Peter G Chandler; Ashley M Buckle
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.